Concepedia

Jonathan R. Green

JR

20

Publications

2.5K

Citations

17

H-Index

1973

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

University of Liverpool

University of Aberdeen

Jonathan R. Green is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and osteoporosis.

Top concepts

Publications per year

1973–2015

20

Publications

20

Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid

Jeanette M. Wood, Karine Bonjean, Stephan Ruetz et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 844 citations

Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound

Jonathan R. Green, Klaus Müller, Knut A. Jaeggi · Journal of Bone and Mineral Research · 1994 · 420 citations

, , +19

Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs

Jean‐Michel Rondeau, Francis Bitsch, E. Bourgier et al. · ChemMedChem · 2006 · 222 citations

, , +22

Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen‐induced arthritis

Natalie A. Sims, Jonathan R. Green, Markus Glatt et al. · Arthritis & Rheumatism · 2004 · 126 citations

The bisphosphonate zoledronic acid has antimyeloma activity<i>in vivo</i>by inhibition of protein prenylation

Andreas Guenther, Sharon Gordon, Markus Tiemann et al. · International Journal of Cancer · 2009 · 122 citations · Full text

Rows per page

1–5 of 20